Is Salvage of Recently Infected Breast Implant After Breast Augmentation or Reconstruction Possible? An Experimental Study. by CASTUS, Pascal et al.
ORIGINAL ARTICLE BASIC SCIENCE/EXPERIMENTAL
Is Salvage of Recently Infected Breast Implant After Breast
Augmentation or Reconstruction Possible? An Experimental
Study
P. Castus1 • O. Heymans2 • P. Melin3 • L. Renwart2 • C. Henrist4 • E. Hayton5 •
S. Mordon6 • F. M. Leclère6,7,8
Received: 15 September 2017 / Accepted: 13 November 2017 / Published online: 23 January 2018
 Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery 2018
Abstract
Introduction The reinsertion of an infected implant when
peri-prosthetic infection occurs early after breast augmen-
tation or breast reconstruction remains controversial. In this
experimental study, the authors tried to remove bacteria,
and their biofilm, from the colonized surface of breast
prostheses, without damaging their integrity.
Materials and Methods A total of 112 shell samples of
silicone breast prostheses, smooth (SPSS) and textured
(TPSS), were colonized by S. epidermidis (SE) or S. aureus
(SA) strains, all able to produce biofilms. After 15 days, all
the samples were removed from the contaminated culture
broth and constituted 4 groups of 20 contaminated samples:
SPSS/SE (group I), SPSS/SA (group II), TPSS/SE (group
III), TPSS/SE (group IV). In another group—group SEM-,
16 colonized samples were used for documentation with
scanning electron microscopy (SEM). The remaining 16
samples were used to test the limits of detection of the
sterility test. All samples of groups I–IV and 8 samples of
group SEM were « washed » with a smooth brush in a
povidone-iodine bath and rinsed with saline solution. A
subset of the washed samples was sent for SEM and the
others were immersed in sterile broth and were incubated at
35 C for 3 weeks (groups I–IV).
Results Fifteen days after contamination, all the samples in
groups I–IV were colonized. In the SEM group, SEM
images attested to the presence of bacteria in biofilm
attached to the shells. After cleaning, SEM did not reveal
any bacteria and there was no visible alteration in the outer
structure of the shell. Sterility tests performed after
decontamination in groups I–IV remained negative for all
the samples.
Conclusion Breast prostheses recently contaminated with
Staphylococci, frequently involved in peri-prosthetic breast
implant infection and capable of producing biofilms, can be
efficiently decontaminated by the procedure used in this
study. Our decontamination procedure did not alter the
surface structure of the prostheses. This decontamination
procedure could allow reinsertion of an infected implant
when peri-prosthetic infection occurs early after breast
augmentation or breast reconstruction and when a salvage
procedure is indicated.
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Introduction
Infection is the leading cause of morbidity after breast
implantation and complicates 2.0–2.5% of interventions in
most case series. Two-thirds of infections develop in the
acute post-operative period [1, 2].
Organisms most often involved in breast prosthesis
infection are Staphylococci (68.2%), usually S. aureus or S.
epidermidis [3]. These organisms belong to normal skin
flora and can colonize mammary ducts [4–8]. After incision
of the skin and transection of the mammary ducts, the
breast pocket is rapidly colonised. A brief skin contact can
be sufficient for prosthesis contamination. It has been
demonstrated that organisms can adhere to breast implants
after only 2 min of contact [9].
Management of early breast prosthesis infection after
breast augmentation or breast reconstruction is contentious.
Opinions remain divided regarding either a two-stage
replacement procedure, with removal and delayed rein-
sertion after 6 months, which remains the gold standard
[10, 11], or a more aggressive, one-stage management,
which involves thorough cleaning of the pocket after
prosthesis removal and insertion of a new implant
[1, 12–17].
In the context of one-stage surgical management, the
aim of this study was to determine if bacteria and their
biofilms could be removed from a recently colonized breast
prosthesis, without damaging the implant. In other words,
when salvage is indicated, is reinsertion of the same
prosthesis after decontamination feasible?
Materials and Methods
This experimental study was performed following the
ethical guidelines of the University of Liège. A total of 112
shell samples of silicone breast prostheses, smooth (SPSS)
and textured (TPSS), were colonized by S. epidermidis
(SE) or S. aureus (SA) strains, all able to produce biofilms.
The study protocol is summarized in Fig. 1.
Organisms
Two strains of Staphylococcus originally isolated from
infected intra-vascular catheters cultured in the medical
microbiology laboratory were used: Staphylococcus epi-
dermidis F0038576 and Staphylococcus aureus F0041616.
These strains were inoculated onto sheep’s blood Columbia
agar and incubated overnight at 35 C. Colonies were
harvested and suspended in sterile saline solution. The
turbidity of each suspension was adjusted to 0.5 MacFar-
land barium sulfate standard, equivalent to 108 colony-
forming units (CFU) per ml. To assess the number of CFU/
ml, a series consisting of tenfold dilutions of the bacterial
suspension was quantitatively inoculated onto sheep’s
blood Columbia agar. Numbers of colonies were assessed
after overnight incubation at 35 C.
Breast Implants
Two types of breast implants were studied: Smooth sur-
face, cohesive gel filled prosthesis (Mentor Corporation
Santa Barbara, CA, USA) and Siltex textured surface,
cohesive gel filled prosthesis (Mentor Corporation Santa
Barbara, CA, USA). In sterile conditions, 56 rectangular
samples of 2.5 9 1 cm2 were punched from the prosthesis
shells. Any remaining silicone gel on the internal side of
the samples was removed with sterile gauze. A total of 112
samples were tailored. Each one was placed in a single
sterile Petri dish to constitute 4 groups of 20 samples:
SPSS/SE (group I), SPSS/SA (group II), TPSS/SE (group
III), TPSS/SE (group IV). In another group—group SEM-,
16 samples were used for documentation with scanning
electron microscopy (SEM). The remaining 16 samples
were used to test the limits of detection in the sterility test
(group TEST).
Contamination and Colonization
Each sterile shell sample of groups I–IV and group SEM
was immersed in 10 ml of Columbia broth and further
contaminated with 100 ll of a 108 CFU/ml suspension of
Staphylococcus aureus or Staphylococcus epidermidis. For
each type of prosthesis, 24 segments were contaminated
per species of Staphylococcus. These cultures were incu-
bated for 15 days at 35 C (Fig. 1). After 15 days, all the
samples were extracted from the contaminated culture
broth. Contamination of the sample was attested by the
presence of bacteria fixed on the wall of the tube and tur-
bidity of the culture medium.
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Decontamination
After 2 weeks, the colonized segments of groups I–IV and
8 colonized segments of group SEM were taken from the
culture tube and were submitted to the decontamination
procedure (Fig. 1). They were immersed in a 100% povi-
done-iodine (Iso-Betadine Dermique, PVP-I 10% solution
aqueuse Purdue Frederick, Stamford, CT, USA) bath and
both sides were cleaned with a sterile smooth brush. This
procedure took\ 1 min for each sample. Then, the sam-
ples were rinsed with a saline solution and dried with
sterile gauze. Acute peri-prosthetic infection occurs, on
average, 10–12 days (minimum 6 days and maximum
6 weeks) after surgery [2]. This is why our decontamina-
tion procedure was carried out on day 15, corresponding to
the time of a potential salvage procedure in surgical
practice.
Sterility Testing
To detect surviving microorganisms after decontamination,
each sample was immersed in 10 ml of Columbia broth and
incubated at 35 C for 3 weeks. Cultures were examined
for growth every day. Growth was assessed by the presence
of turbidity. If a positive culture occurred, it was inoculated
onto sheep’s blood Columbia agar and incubated at 35 C
to check if the contaminant was the initial contaminating
species, S. aureus or S. epidermidis (Fig. 1).
Limits of Detection in the Sterility Test (Group
TEST)
To determine the lower limits of recovery and detection of
surviving microorganisms in small numbers from con-
taminated samples of prosthetic materials (1 9 2.5 cm), 4
segments per type of prosthetic material and per species of
Staphylococcus were contaminated on their outer surface
with 100 ll of bacterial suspensions containing, respec-
tively, 1, 10, 102 and 103 bacteria. These samples were left
at room temperature for 1 h in an aseptic environment.
Each segment was then examined for surviving microor-
ganisms, as outlined above (Fig. 2).
Scanning Electron Microscopy (Group SEM)
Submission to the scanning electron microscopy (SEM)
analysis was performed after 2 weeks contamination
(subgroup SEM?) and after decontamination (subgroup
SEM-). For each strain and for each type of prosthetic
material, 2 colonized (SEM?) and 2 ‘washed’ (SEM-)
samples were submitted for SEM analysis (Fig. 1). All
specimens were immersed in a 0.1 M cacodylate buffer
solution. A fixing step was applied by soaking the samples
for 45 min in a glutaraldehyde solution (2.5 vol% in 0.1 M
cacodylate buffer) at room temperature. The samples were
then rinsed with water and lyophilized. A Pt conductive
coating was deposited by plasma sputtering (Balzers). The
samples were mounted on aluminium holders and observed
at 15 kV in a FEG-ESEM (XL30 from FEI company)
under high vacuum. Each specimen was viewed at a
magnification of 100–1000.
Fig. 1 Rectangular samples (48 2.5 9 1 cm2) were punched in the
smooth and in the textured prosthesis shells. A total of 96 samples
were tailored. For each type of prosthesis, 24 samples were
contaminated per species of Staphylococcus and submitted to the
sterility test. CFU colony-forming units, SEM scanning electron
microscopy
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Data Analysis
In this study, 112 shell samples of silicone breast pros-
theses, smooth and textured, were colonized by S. epider-
midis or S. aureus strains, capable of producing biofilms.
Data analysis was performed using the SPSS program
(SPSS 22.0).
Results
Limits of Detection in the Sterility Test (Group
TEST)
The lower limits of recovery of surviving microorganisms
from quantitatively contaminated segments of prosthetic
materials were 1 CFU for the smooth prosthetic material
either for S. aureus or S. epidermidis and 10 CFU for the
textured material. These results are not statistically differ-
ent from microbiological cultures of serial 10th dilutions
used for contamination.
Groups I–IV
Two weeks after contamination, colonization of the sili-
cone samples was confirmed for all 20 samples in group I
(SPSS/SE), II (SPSS/SA), III (TPSS/SE), and IV (TPSS/
SE) (Fig. 3). Three weeks after the decontamination pro-
cedure, the four sets of cultures corresponding to each
contaminating organism per type of prosthetic material
were negative. These results are summarized in Table 1.
Fig. 2 Eight rectangular samples (2.5 9 1 cm2) were punched in the
smooth and in the textured prosthesis shells. A total of 16 samples
were tailored. For each type of prosthesis and per species of
Staphylococcus, 4 samples were used to determine the limits of
detection in the sterility tests. CFU colony-forming units, SEM
scanning electron microscopy
Fig. 3 Contamination of the sample was attested by turbidity of the
culture medium (a) and the presence of bacteria fixed on the wall of
the tube (b)
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Group SEM
After contamination, SEM analysis of the outer surface of
the samples in group SEM?, textured or smooth, showed
bacterial colonies gathered in groups of 10 bacteria, coated
in bioslime (Fig. 4). Bacterial concentration on the outer
surface of the implants appeared to be lower in the textured
group. After decontamination, no remaining bacteria could
be seen on the outer surface of the samples in group
SEM-. The structure of the outer surface of the shell was
not affected by the decontamination procedure.
Discussion
In this study, 112 shell samples of silicone breast pros-
theses, both smooth and textured, were colonized by S.
epidermidis or S. aureus strains capable of producing
biofilms. Fifteen days after contamination, all the samples
were colonized. SEM images demonstrated the presence of
bacteria and biofilm fixed on the shells. Sterility tests
performed after decontamination in all groups of implants
remained negative for all samples. After cleaning, SEM did
not reveal any organisms and there was no alteration in the
outer structure of the shell surface.
The organisms most commonly implicated in breast
prosthesis infection are Staphylococci (68.2%), usually S.
aureus or S. epidermidis [3]. Staphylococci produce an
exopolysaccharide extracellular material commonly refer-
red to as slime. This slime production is enhanced in the
presence of a foreign body [18]. Even in individuals with
excellent cellular and humoral immunity, biofilm infec-
tions are rarely eradicated by the host defence mechanisms
[19]. Antimicrobial therapy usually fails to kill bacteria
within the biofilm [20]. After conservative treatment alone,
biofilm and entrapped bacteria may continue to grow and
cause subclinical infection, which may play a major role in
capsular contracture [21, 22], and may act as a reservoir for
acute exacerbations. Indeed, some of the ‘‘sessile’’ organ-
isms may be released by the biofilm and become ‘‘plank-
tonic’’, initiating a new acute peri-prosthetic infection. The
only way definitively to eradicate infection is to surgically
eliminate the organisms fixed on the surface of the foreign
body.
In this context, the first step of our study was to create a
model of an infected implant: Two strains of Staphylococci
originally isolated from infected intra-vascular catheters
and two frequently used types of prostheses (smooth and
textured) were used to mimic the clinical scenario. After
2 weeks, all samples were colonized by groups of bacteria
(S. Epidermis or S. aureus). SEM images showed colonies
of about ten cells, embedded in their bioslime (Fig. 4c). It
has been shown that the physical characteristics of a sur-
face (rough or smooth) influence bacterial adhesion to only
Table 1 Number of positive tests and limits of detection in the sterility tests in the four sets of cultures corresponding to each contaminating





Number of positive tests after
decontamination
Limits of detection in the sterility tests
(CFU)
Smooth S. aureus 0/20 1
S. epidermidis 0/20 1
Textured S. aueus 0/20 10
S. epidermidis 0/20 10
Fig. 4 Scanning electron microscopy (SEM) shows bacteria colonies
fixed on the outer surface of the prosthesis shells. a Smooth surface
prosthesis covered by Staphyloccus aureus colonies, located with
white arrows (Original magnification 9100), b textured surface
prosthesis covered by Staphylococcus epidermidis colonies, located
with white arrows (Original magnification 9100), c high magnifica-
tion of two Staphylococcus aureus colonies (Original magnification
92000)
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a minor extent [23]. In our study, colonies seemed to be
less dense in the textured group but this was not statisti-
cally significant and SEM was only used to obtain images
of the colonization of the prosthesis samples.
The second step was to try to disunite the bioslime, and
the embedded cells, from the implants. Once a biofilm has
formed and the exopolysaccharide matrix has been secreted
by the sessile cells, the resultant structure is highly vis-
coelastic and behaves rather like rubber. Donlan and
Costerton have clearly demonstrated that biofilms formed
in low-shear environments (as in our situation) have a low
tensile strength and break easily, but biofilms formed at
higher shear (i.e., rapidly flowing milieus) are remarkably
strong and resistant to mechanical breakage [24]. To break
the biofilm, the colonized shell samples were immersed in
a povidone-iodine bath and gently cleaned with a smooth
brush [2]. The mechanical action of the smooth brush is
necessary to detach the fixed colonies. Moreover, the
antiseptic action of Betadine against bacteria like S. epi-
dermidis and their biofilm has been well documented in the
literature [25]. The integrity of the samples after this
combined procedure was evidenced in this study. The
minor disruptions induced by a smooth brush on the
prosthesis were insignificant compared to the tests per-
formed at the factory (Mentor Corporation Santa Barbara,
Calif.). Moreover, the decision to use Betadine was also
affirmed by the experimental study of Zambacos and
Nguyen [26], who studied the effects of different concen-
trations of povidone-iodine (0.01–10%) on silicone shells
and found no structural modification [26]. In other words, a
brief contact of the implant with Betadine, during the
decontamination procedure, and followed by copious saline
solution irrigation, has no effect on the long-term integrity
of the shell of the implant. This is also confirmed by the
SEM analysis of the SEM- group, which demonstrates
integrity of the samples. Finally, this combination of
antiseptic and manual dissolution was effective because
3 weeks after the decontamination procedure, the four sets
of cultures corresponding to each contaminating organism
per type of prosthetic material were negative and analysis
of the surface of the implants in SEM? group did not
reveal any residual bacteria. It should be emphasized that
when a breast implant is inserted or reinserted, it is
impossible to exclude bacterial contamination of the pocket
and/or the implant, even if all necessary precautions are
taken (decontamination of the implant, disinfection of the
pocket, minimal operating time, no skin contact with the
implant, and so on). The key is to reduce the bacterial load
to such a point that the remaining bacteria can be elimi-
nated or controlled by the host.
Despite the encouraging results obtained in this study,
some limitations are to be noted: (1) Only two strains of
Staphylococcus were used in this study. Samples
contaminated with a higher number, or several strains of
bacteria [27–30] may better mirror the numerous clinical
situations with different time frames and hospital contam-
inants. Moreover, the bacterial content of the breast
implant pocket could not be studied. However, Pittet et al.
[2] clearly demonstrated that S. aureus or S. epidermidis
are the most common causative organisms in breast pros-
thesis infections. (2) Additionally, the limits of detection in
the sterility tests were slightly different in both groups, but
as previously mentioned, this difference is not significant
from the microbiological point of view. In the smooth
prosthesis group, 1 CFU is the limit, versus 10 CFU in the
textured prosthesis group. This means that even if the
sterility tests are negative 3 weeks after the decontamina-
tion procedure, we cannot exclude that one bacterium
might be left on the textured shell group and fewer than 10
bacteria on the smooth shell. Indeed, bacteria subject to
harsh conditions may ‘‘hibernate’’ until conditions are
more favorable for proliferation. (3) Finally, the low
number of samples in the SEM groups meant they could
only serve as photographic documentation. A higher
number of samples may have better defined the link
between the type of implant and its influence on bacterial
adhesion.
Conclusion
Breast prostheses recently contaminated with strains of
Staphylococci, frequently involved in peri-prosthetic breast
implant infection and capable of producing biofilms, can be
efficiently decontaminated by the procedure used in this
study. Our decontamination procedure did not alter surface
structure. This decontamination procedure could allow
reinsertion of an infected implant when peri-prosthetic
infection occurs early after breast augmentation or breast
reconstruction and when a salvage procedure is indicated.
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